18 completed, 3 unknown, 2 active not recruiting, 2 terminated. 6 Phase 3, 6 Phase 4, 5 Phase 1, 5 Phase 2, 2 Early Phase 1.
Follow clindamycin phosphate: new trials by email Literature Review of clindamycin phosphate trials Research Report on clindamycin phosphate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Triple Combination Gel in Canadian Patients With Acne Vulgaris clindamycin phosphate, adapalene and benzoyl peroxide - Acne Vulgaris | Completed | Bausch Health Americas, Inc. | 200 | 2025-10-02 | 2026-09-09 | |
| A Study Comparing Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Topical Gel 0.15%;3.1%;1.2% (Taro Pharmaceuticals U.S.A., Inc.) and CABTREO Topical Gel for the Treatment of Acne Vulgaris. Clindamycin Phosphate, Adapalene, and Benzoyl Peroxide Topical Gel 0.15%;3.1%;1.2%, CABTREO Topical Gel, Placebo Control - Acne Vulgaris | Phase 1 | Completed | Sun Pharmaceutical Industries, Inc. | 382 | 2024-05-13 | 2024-11-05 |
| Experience With Topical Acne Treatment clindamycin phosphate 1.2%/adapalene 0.15%/BPO 3.1% gel, adapalene 0.3%/BPO 2.5% gel and compounded clindamycin phosphate 1.2% gel, Compounded BPO 2.5% gel, adapalene 0.1% gel, and compounded clindamycin phosphate 1.2% gel - Acne | Early Phase 1 | Active not recruiting | Wake Forest University Health Sciences | 72 | 2024-02-15 | 2025-12-24 |
| Title of the Protocol: Combined Use of Vaginal Clindamycin Cream and Oral Metronidazole Versus Oral Metronidazole Clindamycin Phosphate - Bacterial Vaginosis | Not applicable | Completed | Ain Shams Maternity Hospital | 100 | 2024-01-10 | 2025-11-25 |
| Vancomycin and Tobramycin Powder Use in Acute Open Fractures Cephalosporin or clindamycin/vancomycin antibiotics.., Vancomycin and Tobramycin antibiotics. - Infections | Early Phase 1 | Completed | University of Utah | 10 | 2023-03-27 | 2024-12-20 |
| Clindamycin and Triamcinolone in People With Glioblastoma to Prevent Skin-Related Side Effects of Tumor Treating Fields Clindamycin Phosphate, Triamcinolone Acetonide - Glioblastoma, Recurrent Glioblastoma | Phase 2 | Active not recruiting | Memorial Sloan Kettering Cancer Center | 48 | 2020-07-09 | 2026-08-10 |
| Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris Clindamycin Phosphate, Clindamycin Phosphate RLD, Placebos - Acne Vulgaris | Phase 1 | Completed | Sun Pharmaceutical Industries, Inc. | 550 | 2019-09-09 | 2025-04-10 |
| Antibiotic Irrigations for Intra-Abdominal Drains Gentamicin Sulfate Inj 20mg/2ml vial for injection, Clindamycin phosphate 6 mg/1ml for injection, Placebo - Abdominal Abscess | Phase 2 | Terminated | University of Iowa | 2 | 2019-04-01 | 2026-09-03 |
| Efficacy of Oral Antibiotic Therapy Compared to Intravenous Antibiotic Therapy for Osteomyelitis Intravenous Antibacterial Agent, Oral Antibacterial Agent - Osteomyelitis | Phase 2 | Terminated | Loyola University | 30 | 2014-03-19 | 2018-07-19 |
| To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel, DUAC® Gel, Placebo - Acne Vulgaris | Phase 3 | Completed | Zydus Lifesciences Limited | 850 | 2013-11-01 | 2020-10-14 |
| Safety and Pharmacokinetics of Clindamycin in Pediatric Subjects With BMI ≥ 85th Percentile Clindamycin - Bacterial Infections, Obesity | Phase 1 | Completed | Phillip Brian Smith | 22 | 2013-06-01 | 2016-11-29 |
| Study Comparing Clindamycin Phosphate and Benzoyl Peroxide Gel to Acanya® Gel and Both to a Vehicle Control in the Treatment of Acne Vulgaris Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/2.5%, Acanya® Gel, 1.2%/2.5%, Vehicle of test product - Acne Vulgaris | Phase 1 | Completed | Sun Pharmaceutical Industries, Inc. | 1215 | 2012-11-01 | 2017-05-05 |
| Evaluate Therapeutic Equivalence and Safety of Two Clindamycin Phosphate and Benzoyl Peroxide Gels in Acne Vulgaris Clindamycin Phosphate / Benzoyl Peroxide Gel, Clindamycin Phosphate and Benzoyl Peroxide Gel, 1.2%/2.5%, Placebo (Vehicle Gel) - Acne Vulgaris | Phase 3 | Completed | Watson Laboratories, Inc. | 708 | 2012-07-01 | 2013-02-11 |
| A Study to Compare Clindamycin Phosphate and Benzoyl Peroxide Topical Gel 1.2%/2.5% to Acanya® Topical Gel in the Treatment of Acne Vulgaris Clindamycin Phosphate and Benzoyl Peroxide Topical Gel 1.2%/2.5%, Acanya Gel, Placebo of Clindamycin Phosphate and Benzoyl Peroxide Topical Gel 1.2%/2.5% product - Acne | Phase 3 | Completed | Padagis LLC | 1180 | 2012-02-01 | 2021-10-22 |
| Safety and Tolerability of Acanya Gel in Combination With Atralin Gel for Acne Vulgaris Benzoyl peroxide 2.5%/clindamycin phosphate 1.2% in the morning with with tretinoin 0.05% gel in the evening - Acne Vulgaris | Phase 4 | Unknown | Zeichner, Joshua, M.D. | 20 | 2011-07-01 | 2011-10-07 |
| A Study Comparing Combination Clindamycin Phosphate/Tretinoin Gel Alone Versus With Benzoyl Peroxide Foaming Cloths for Facial Acne clindamycin phosphate 1.2%/tretinoin 0.025% gel alone, clindamycin phosphate 1.2%/tretinoin 0.025% gel plus benzoyl peroxide 6% foaming cloths - Acne Vulgaris | Phase 4 | Unknown | Zeichner, Joshua, M.D. | 40 | 2011-07-01 | 2011-08-24 |
| Efficacy & Safety of Clindamycin and Tretinoin in Acne Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel - Acne | Phase 4 | Unknown | Callender Center for Clinical Research | 30 | 2009-11-01 | 2010-05-20 |
| A Phase 4, Single-Blind, Randomized, Study to Compare the Tolerability and Efficacy of 0.1% Tazorac Cream When Used in Combination With Either Duac Gel or Acanya Gel for the Treatment of Facial Acne Vulgaris Clindamycin 1%/Benzoyl Peroxide 5% and 0.1% tazarotene, clindamycin phosphate 1.2%/benzoyl peroxide 2.5% and 0.1% tazarotene - Acne Vulgaris | Phase 4 | Completed | Stiefel, a GSK Company | 40 | 2009-10-01 | 2017-01-30 |
| Compare the Tolerance of Clindamycin 1% /Benzoyl Peroxide (BPO) 5% Gel to Clindamycin 1.2%/ BPO 2.5% Topical Medications Clindamycin and BPO 5% gel, Clindamycin phosphate and benzoyl peroxide 2.5% gel. - Acne Vulgaris | Phase 4 | Completed | Stiefel, a GSK Company | 36 | 2009-08-01 | 2017-03-31 |
| Adherence to Study Medication Compared to Generic Topical Clindamycin Plus Generic Topical Tretinoin in Subjects With Mild to Moderate Acne Vulgaris clindamycin phosphate 1.2% and tretinoin 0.025%, clindamycin 1% gel, tretinoin 0.025% cream - Acne Vulgaris | Phase 4 | Completed | Wake Forest University | 26 | 2009-03-01 | 2018-09-10 |
Showing 20 of 25. Sign in to see all of them.
Acne Vulgaris (15) · Vaginitis (2) · Vaginosis, Bacterial (2) · Abdominal Abscess (1) · Bacterial Infections (1) · Diabetes Mellitus (1) · Glioblastoma (1) · Hyperpigmentation (1) · Infections (1) · Obesity (1) · Osteomyelitis (1) · Recurrence (1) · Rosacea (1) · Vulvovaginitis (1)
Sun Pharmaceutical Industries, Inc. (3) · Lumara Health, Inc. (2) · Stiefel, a GSK Company (2) · Zeichner, Joshua, M.D. (2) · Ain Shams Maternity Hospital (1) · Bausch Health Americas, Inc. (1) · Callender Center for Clinical Research (1) · Hadassah Medical Organization (1) · Loyola University (1) · Massachusetts General Hospital (1) · Memorial Sloan Kettering Cancer Center (1) · Padagis LLC (1) · Phillip Brian Smith (1) · Skaraborg Hospital (1) · University of Iowa (1)
United States (17) · India (3) · Russia (2) · Canada (1) · Egypt (1) · Israel (1) · Puerto Rico (1)
Jim Joffrion (2) · Natalie Yantovskiy (2) · Alexa Kimball, MD, MPH (1) · Alina Markova, MD (1) · Arie Ingber, MD, Prof (1) · Dr Dharmesh Domadia, M.D (1) · Elka Touitou, PhD, Prof (1) · John L Capicchioni (1) · Justin Haller, M.D. (1) · Kevin Watt, MD (1) · Laila Aly Farid, Professor (1) · Michael J Smith, MD (1) · Michael Pinzur, M.D. (1) · P. Brian Smith, MD, MHS, MPH (1)